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ABSTRACT
Objectives: To investigate whether life event stress
was associated with greater psychological distress and
poorer quality of life in older individuals with chronic
obstructive pulmonary disease (COPD), in comparison
with their counterparts without COPD.
Design: Cross-sectional study.
Participants: A population-based sample (N=497) of
individuals aged 65 and above with COPD
(postbronchodilatation FEV1/FVC<0.70, N=136) and
without COPD (N=277).
Measurements: We measured life event stress,
depressive symptoms (GDS, Geriatric Depression
Scale), cognitive symptoms and function (CFQ,
Cognitive Failures Questionnaire and MMSE, Mini-
Mental State Examination), and physical and mental
health functional status (SF36-PCS, Physical Health
Component Summary and SF36-MCS, Mental Health
Component Summary) in participants with and without
COPD.
Results: In two-way analysis of variance controlling
for potential confounders, life event stress was
associated with significant main effects of worse GDS
(p<0.001), SF36-PCS (p=0.008) and SF36-MCS scores
(p<0.001), and with significant interaction effects on
GDS score (p<0.001), SF36-PCS (p=0.045) and SF36-
MCS (p=0.034) in participants with COPD, more than
in non-COPD participants. The main effect of COPD
was found for postbronchodilator FEV1 (p<0.001) and
cognitive symptoms (p=0.02).
Conclusions: Our findings indicate that life event
stress was associated with more depressive symptoms
and worse quality of life in individuals with COPD,
much more than in those without COPD. Further
studies should explore the role of cognitive appraisal of
stress, coping resources and psycho-social support in
this relationship.
INTRODUCTION
Chronic obstructive pulmonary disease
(COPD) stands out among chronic diseases
with its high and rising prevalence and
mortality,1 poor quality of life, frequent hos-
pitalisation and huge societal burden of
care.2 Because patients with COPD bear a
heavy burden of psychological disturbance,
psychiatric morbidity and disability in daily
living activities,3 4 the mental health of
COPD patients has received growing atten-
tion in recent years.
Life event stress is increasingly recognised to
play important roles in the development and
outcomes of chronic illness such as type II dia-
betes, coronary heart disease, gastroentero-
logical disorders and obstetric outcomes.5
Stress is well known to result in depression,
psychological burnout, post-traumatic stress
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▪ The impact of life event stress on the mental
well-being and quality of life of individuals with
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Key messages
▪ Our findings showed that in individuals with
COPD, life event stress had a greater detrimental
effect on mental health and quality of life in com-
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Strengths and limitations of this study
▪ The case definition for COPD in this study was
accurately based on symptom and postbronchial
dilatation spirometric measures of chronic airflow
obstruction that are diagnostic of COPD according
to Global Initiative for Chronic Obstructive Lung
Disease (GOLD)-recommended criteria.
▪ The results from this general population-based
study are largely free of clinical selection bias,
and also controlled for important confounding
by demographic and psychosocial variables in
the analysis.
▪ Definite causal inferences cannot be made from
the cross-sectional findings in this study. Further
longitudinal studies are required.
Lu Y, Nyunt MSZ, Gwee X, et al. BMJ Open 2012;2:e001674. doi:10.1136/bmjopen-2012-001674 1
Open Access Research
 group.bmj.com on April 9, 2013 - Published by bmjopen.bmj.comDownloaded from 
disorder (PTSD) in all age groups, as well as cognitive
impairment in late life.6 Among COPD patients, an intrin-
sic source of stress is directly related to their illness, involv-
ing the experience of anxiety and distress provoked by
breathing difﬁculties,7 8 including muddled thoughts,
heightened emotions, extreme fear and panic and
decreased physical energy, and various difﬁculties in emo-
tional functioning, sleep and rest, physical mobility, social
interaction, activities of daily living, recreation, work and
ﬁnance. However, the impact of life event stress in general,
including those extrinsic to illness-related experience on
the physical and mental functioning and quality of life of
individuals with COPD in comparison with non-COPD
individuals, has rarely been investigated.6 9 10 The aim of
this study was to investigate whether life event stress was
associated with greater psychological distress and poorer
quality of life in older individuals with COPD, in compari-
son with their counterparts without COPD.
The present study analysed data collected on COPD
status, life event stress and measures of pulmonary func-
tion, cognitive function, depressive symptoms and
quality of life in a population-based sample (Singapore
Longitudinal Ageing Study)11 to investigate the effect of
life event stress on psychological functioning and quality
of life. We hypothesised that life event stress in the
whole sample would be associated with depressive symp-
toms and poor quality of life (main effect), but would
have a stronger association among individuals with
COPD than among non-COPD individuals (interaction),
suggesting a greater detrimental effect on depressive
symptoms and quality of life. A secondary relationship
analysed in two-way analysis of variance (ANOVA)
was the main effect of the COPD status (and its inter-
action with life event stress) on primary outcomes of
pulmonary and cognitive function, based on the
known effects of impaired pulmonary and cognitive
function in COPD.
METHODS
Study design and participants
The participants in the study were a subsample recruited
from one locality (Bukit Merah) in the South Central
region of Singapore Longitudinal Ageing Study
(SLAS-2), a prospective population-based cohort study of
ageing and health of community-dwelling elderly.12 We
interviewed one participant from each household who
were Singaporean citizens or permanent residents aged
65 or older who were able to give informed consent.
Those who were too frail or ill and unable to complete
the interview, for reasons such as from poststroke
aphasia, cachexia or profound dementia, were excluded.
The participants who completed interviews and provided
technically acceptable spirometric data (N=497) repre-
sented a response rate of 78.5% of the eligible partici-
pants. All participants signed written informed consent
for the study that was approved by the National University
of Singapore Institutional Review Board.
Chronic obstructive pulmonary disease
We identiﬁed cases of COPD among the participants who
had characteristic symptoms of COPD and spirometric
evidence of chronic airﬂow obstruction (postbronchial
dilatation FEV1/FVC<0.70), in accordance with the def-
inition recommended by the Global Initiative for
Chronic Obstructive Lung Disease (GOLD).13
Questions from the British Medical Research Council
Questionnaire on chronic respiratory symptoms were
used to elicit symptoms characteristic of COPD: chronic
cough and/or sputum lasting at least 3 months in the
year and/or breathlessness on exertion.
Ventilatory function testing was performed using a port-
able, battery-operated, ultrasound transit-time-based spir-
ometer (Easy-One; Model 2001 Diagnostic Spirometer,
NDD Medical Technologies, Zurich, Switzerland).
Calibration was checked daily with a 3-litre syringe. Forced
expiratory manoeuvres were performed with the respond-
ent seated with recommended guidelines and standardisa-
tion of procedures: at least three acceptable manoeuvres,
with forced vital capacity (FVC) and forced expiratory
volume in the ﬁrst second (FEV1) reproducible within
200 ml. Chronic airﬂow obstruction as deﬁned as post-
bronchial dilatation FEV1/FVC<0.70.
Life event stress
Life event stress was measured by an 11-item life events
inventory 14 15 that excluded personal illness experi-
ences directly related to COPD. The participants were
asked to indicate yes or no as to whether any of 11 life
events had occurred over the past year (‘spouse or
partner die, a close friend or family member die or have
a serious illness (other than your spouse or partner),
major problems with money, a divorce or break up,
family member or close friend have a divorce or break
up, major conﬂict with children or grandchildren, major
accidents, disasters, muggings, unwanted sexual experi-
ences, robberies, or similar events, a family member or
close friend lose their job or retire, physically abused,
verbally abused, or pet die’). If the participant indicated
(a) life event(s) had occurred, he/she was asked to
appraise the event and indicate on a scale of 1 (did not
upset me) to 3 (upset me greatly) the extent it upset
them. Frequency of life event stress was calculated. The
scale also provides a life event stress score appraised by
the participant that ranged from 0 to 33 with a higher
score indicating a participant experienced a greater
number of more stressful events.
Depressive symptoms
The presence of depressive symptoms was determined
by a depression screening scale for elderly populations,
the 15-item Geriatric Depression Scale (GDS-15) with
scores ranging from 0 to 15.16 The GDS was well suited
for the study because it is largely free of the measure-
ment artefact due to overlapping somatic symptoms of
physical illness(es) and depression. In validation studies
in the local older population,17 translated versions of
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the GDS-15 have been found to be a valid and reliable
screening tool for depression: Cronbach’s α of 0.80, and
intraclass coefﬁcients of test−retest reliability of 0.83 and
inter-rater reliability of 0.94. Using a GDS cut-off of ≥5,
the GDS-15 has a sensitivity of 0.97 and speciﬁcity of
0.95 (area under curve of 0.98) for determining major
depressive disorder according to DSM-IV criteria.
Depressive symptoms deﬁned as such by GDS≥5 is clinic-
ally signiﬁcant, and such cases including ‘subthreshold’
depression, had been shown in the same population to
be associated with signiﬁcantly poorer mental and phys-
ical health and functional status, and more healthcare
resource utilisation compared to non-cases and were
similar to or worse than syndrome threshold cases of
depression.18
Cognitive function
Cognitive function was measured using the Cognitive
Failures Questionnaire (CFQ)19 and the mini-mental state
examination (MMSE) which were validated and widely
used instruments to assess global cognitive functioning.20
The CFQ uses a ﬁve-point Likert-type scale (1=Never,
5=Very often) to evaluate self-reported cognitive problems
(eg,‘Do you need to re-read instructions several times?’).
Higher CFQ scores indicate more frequent cognitive
problems and higher MMSE scores (0−30) indicate better
global cognitive functioning, and MMSE scores of 23 or
less are considered to be cognitively impaired.
Physical and mental functioning
Physical and mental functional well-being was measured
by the Medical Outcomes Study 36-item Short Form
(SF-36)21 which has been previously validated for use in
Singaporeans.22 Weighted summary measures of Physical
Health Component Summary (PCS) score and Mental
Health Component Summary (MCS) score were com-
puted with higher scores indicating better physical and
mental health functioning and quality of life.
Statistical analyses
Data analysis was performed using the software package
PASW Statistics (SPSS) V.18. In preliminary univariate
analysis, participants with and without COPD were com-
pared with respect to differences in number of life
events, and perceived stress score, level of FEV1, CFQ,
MMSE, GDS depression, SF-36 PCS and SF-36 MCS
scores, as well as potential confounding variables, sex,
age, ethnicity, smoking status, number of chronic dis-
eases, using t tests or χ2 tests of signiﬁcance. The inde-
pendent main effects of life event stress and COPD
(independent variables) as well as the interaction effects
of life event stress and COPD on measures of pulmonary
function, depressive symptoms, cognitive function and
quality of life (dependent variables) were analysed using
two-way ANOVA using a generalised linear model23
which adjusted for sex, age, ethnicity, smoking status
and number of chronic illness. The independent vari-
able of primary interest was life event stress, and the
primary outcome variables of interest were depressive
symptoms and quality of life. A secondary relationship
analysed in the two-way ANOVA model was the main
effect of COPD status (and its interaction with life event
stress) on primary outcomes of pulmonary and cognitive
function. For the outcome variables with signiﬁcant
interaction of life event stress and COPD, the simple
effects of their relationships with life event stress score
were investigated respectively in participants with and
without COPD. Statistical signiﬁcance was set at p<0.05.
RESULTS
This study consisted of 497 participants with the average
age of 72.1. Among the respondents, 32.9% had COPD,
and 67.1% had no COPD. The proportion of respon-
dents with stressful life events in the past 1 year was
43.4%. The sociodemographic and psychological charac-
teristics of study participants with and without COPD are
shown in table 1. Participants with COPD were found to
have higher mean age (t=3.328, p=0.001), higher pro-
portion of smokers (χ2=20.586, df=3, p<0.001) and
increased number of diseases (t=7.096, p<0.001). No sig-
niﬁcant difference in the number of life events or per-
ceived stress was observed between COPD and
non-COPD participants (p>0.05).
Table 1 shows that compared with those without
COPD, participants with COPD had decreased post-
bronchodilator FEV1 (t=6.185, p<0.001), MMSE score
(t=3.090, p=0.002) and SF-36 PCS (t=2.726, p=0.007)
score. There were no differences in CFQ and GDS
depression scores between participants with and without
COPD (p>0.05) in the whole sample. Next, we evaluated
the effect of life event stress on GDS, CFQ, MMSE, SF-36
PCS and SF-36 MCS scores by subgroups of participants
with COPD and without COPD. As shown in table 2,
two-way ANOVA in general linear model showed signiﬁ-
cant main effects of life event stress for GDS (F=64.500,
df=1, p<0.001), SF36-PCS (F=7.054, df=1, p=0.008) and
SF36-MCS (F=14.710, df=1, p<0.001) scores, and signiﬁ-
cant interactions of life event stress with COPD were
found as well for GDS (F=10.970, df=1, p=0.001),
SF36-PCS (F=4.055, df=1, p=0.045) and SF36-MCS
(F=4.538, df=1, p=0.034) scores. The simple effects of
life event stress on GDS, SF36-PCS and SF36-MCS are
shown for participants with and without COPD, respect-
ively, in ﬁgure 1. Increasing stress score was associated
with higher GDS score, lower SF12-PCS and SF12-MCS
scores in participants with COPD, more than in those
without COPD after adjusting for potential confounders,
indicating the association of life event stress with worse
psychological distress and poorer quality of life among
individuals with COPD, in comparison with non-COPD
individuals. The other signiﬁcant main effect found in
two-way ANOVA was of COPD for decreased postbronch-
odilator FEV1 (F=17.458, df=1, p<0.001) and higher
CFQ scores (F=5.424, df=1, p=0.020) after adjustment of
sex, age, ethnicity, smoking status and number of
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chronic illness, indicating impaired pulmonary and cog-
nitive functions in participants with COPD.
DISCUSSION
The principal ﬁnding in this study indicated that life
event stress was associated with depressive symptoms and
poor quality of life in both COPD and non-COPD parti-
cipants (main effects), but showed a signiﬁcantly stron-
ger association among individuals with COPD than
among non-COPD individuals (interaction), suggesting
a disproportionately greater detrimental effect. To our
knowledge, no other studies have reported demonstrat-
ing this relationship.
It should be noted that participants with COPD actu-
ally did not report greater frequency of occurrence or
perceived stress score of non-illness-related life events
than non-COPD participants. Instead, individuals with
COPD appeared to experience the same number of
non-illness-related life events and perceived them to be
Table 2 Two-way analysis of variance: Life event stress, COPD and mental and physical variables
Main effects of COPD
(df=1)
Main effects of stress
(df=1) Interaction (df=1)
F p Value F p Value F p Value
Postbronchodilator FEV1 17.458 <0.001 0.323 0.570 2.057 0.152
CFQ score 5.424 0.020 1.927 0.166 2.514 0.114
MMSE score 1.799 0.181 1.159 0.282 0.380 0.538
GDS depression score 2.353 0.126 64.500 <0.001 10.970 0.001
SF-36 PCS 0.432 0.512 7.054 0.008 4.055 0.045
SF-36 MCS 0.659 0.417 14.710 <0.001 4.538 0.034
Adjusted variables: sex, age, ethnicity, smoking status and number of chronic illness.
CFQ, Cognitive Failure Questionnaire; FEV1, Forced Expiratory Volume in the first second; GDS, the Geriatric Depression Scale; MCS,
Mental Health Component Summary; MMSE, mini-mental state examination; PCS, Physical Health Component Summary; SF-36, 36-Item
Short-Form Healthy Survey.
Table 1 Sociodemographic, pulmonary and psychological variables of study participants aged 65 or above (Singapore
Longitudinal Ageing Study, SLAS)
COPD Non-COPD
N % N % Significant test p Value
Total 136 32.9 277 67.1
Sex
Male 58 42.6 112 40.7 χ2=0.138, df=1 0.710
Female 78 57.4 163 59.3
Age (years, M±SD) 73.19 ±5.87 71.23 ±5.47 t=3.328 0.001
Ethnicity
Chinese 121 89.0 241 87.6 χ2=0.154, df=1 0.694
Non-Chinese 15 11.0 34 12.4
Smoking
Never smoker 77 57.6 211 77.3 χ2=20.59, df=3 <0.001
Past smoker 29 21.6 41 15.0
Current smoker<10 cigarettes daily 18 13.4 12 4.4
Current smoker≥10 cigarettes daily 10 7.5 9 3.3
Number of chronic diseases 2.60 ±1.30 1.65 ±1.25 t=7.096 <0.001
Number of negative life events 0.67 ±0.98 0.74 ±1.11 t=0.609 0.543
Life event stress score 1.02 ±1.71 1.12 ±1.78 t=0.525 0.600
Postbronchodilator FEV1 1.42 ±0.50 1.75 ±0.52 t=6.185 <0.001
CFQ score 38.0 ±9.21 38.8 ±9.83 t=0.733 0.464
MMSE score 26.4 ±3.26 27.4 ±3.11 t=3.090 0.002
GDS depression score 1.13 ±2.04 0.84 ±1.69 t=1.487 0.138
GDS≥5 7 5.2 8 2.9 χ2=1.349, df=1 0.245
SF-36 PCS 44.6 ±9.04 47.1 ±7.21 t=2.726 0.007
SF-36 MCS 54.9 ±7.83 55.1 ±6.68 t=0.353 0.724
Figures in table denote mean±SD or number and %.
Smoker is defined as smoking≥10 cigarettes daily.
COPD, chronic obstructive pulmonary disease; CFQ, Cognitive Failures Questionnaire; GDS, the Geriatric Depression Scale; MMSE,
mini-mental state examination; SF-36 MCS, 36-Item Short-Form Mental Health Component Summary; SF-36 PCS, 36-Item Short-Form
Physical Health Component Summary.
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equally stressful as their non-COPD counterparts, yet
showed disproportionately greater psychological distress
and poorer quality of life. These results suggest that indi-
viduals with COPD may be more vulnerable to the
adverse impact of stressful events than non-COPD
individuals.
A greater detrimental effect of life event stress on psy-
chological well-being and quality of life in COPD indivi-
duals may hypothetically be explained by the possibility
that COPD individuals perceive and appraise stressful
life events differently to individuals without COPD, or
that COPD individuals have poorer coping skills or
fewer social and economic resources, or both. We did
not have measures of cognitive appraisal, coping
resources and social support to explore these hypotheses
directly, and this is a limitation of our study.
There are few studies that have investigated the rela-
tionship between cognitive appraisal of stressful events,
coping strategies and psychological distress in COPD
patients. A study by Andrenas and co-investigators24 have
assessed how hospitalised patients with acutely exacer-
bated COPD appraised and coped with a recent stressful
event and their level of psychological distress. They
reported that half of the respondents tended to perceive
their stressful event as representing a threat, 26% as
harmful, 7.6% as a loss, 4.3% as a challenge and 11%
characterised the stressful event in some other ways.
However, the authors found that neither types of stress-
ful event, stress intensity, primary or secondary appraisal,
or number of coping strategies used were signiﬁcantly
related to psychological distress. Only problem-solving
coping strategies were inversely related to psychological
distress. This suggests that poor coping skills may be the
principal psychological problem among COPD patients
that contribute to their psychological distress and poor
quality of life. However, further studies should be
conducted.
Our secondary ﬁnding of the main effects of COPD
on FEV1 was expected and thus not surprising. However,
the association of COPD with more frequent cognitive
problems was interesting, although the results for MMSE
score were not signiﬁcant after adjustment in two-way
ANOVA, possibly due to sample size limitation. These
results are consistent with clinical and population
studies that indicate signiﬁcant cognitive effects of
COPD on deﬁcits in abstract reasoning,25 complex visual
motor process,26 and verbal learning,27 language,28
attention,29 information processing speed29–31 and
verbal learning and memory.30 31
The present study has strengths and limitations. The
case deﬁnition for COPD is accurately based on
symptom and postbronchial dilatation spirometric mea-
sures of chronic airﬂow obstruction that are diagnostic
of COPD according to GOLD-recommended criteria.
Results from this general population-based study are
largely free of clinical selection bias, and also controlled
for important confounding by demographic and psycho-
social variables in the analysis. The measure of life event
stress is modiﬁed to exclude illness-related stress from
chronic diseases in this older population. However, a
limitation of the life event inventory is inter-categorical
variability and recall bias in the appraisal of the stressful
life event.32 In a cross-sectional study, interpreting the
causal relationship between stress- and the health-related
functional outcomes can be uncertain. Further longitu-
dinal studies are required.
Studies33–35 have reported that mental health status,
including anxiety and depressive symptoms, are better
predictors of COPD-related quality of life than pulmon-
ary function. The present study supports this observation
and further indicates that life event stress has a starkly
detrimental effect on mental health and quality of life
in patients with COPD. More studies of the effects of
stress management and coping strategy in psychological
interventions in COPD should be investigated in rando-
mised controlled clinical trials.
It is increasingly being recognised that the identiﬁca-
tion of mood and anxiety disorders, and psychological
and psychosocial interventions to improve mood and
reduce anxiety are important for improving patient-
centred outcomes in COPD patients. However, in pub-
lished clinical guidelines such as NICE, where the initial
step care management by practitioners in primary care
and general hospital settings includes low-intensity psy-
chosocial interventions for patients with persistent sub-
threshold depressive symptoms or mild-to-moderate
depression, there appears to be little attention given to
identifying stressful life event(s) and supporting COPD
patients experiencing stressful life events to prevent the
onset of mood and anxiety disorders. In particular,
group-based peer support, individual-guided self-help
based on cognitive behavioural therapy (CBT) principles
Figure 1 Predicted value for
SF-36 PCS, GDS depression
score and SF 36-MCS in
participants with and without
COPD SF-36=36-Item short-form
Healthy Survey; GDS, the
Geriatric Depression Scale;
MCS, Mental Health Component
Summary; PCS, Physical health
Component Summary.
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or computerised CBT to reduce patients’ vulnerability to
stress may usefully include objective cognitive appraisal
of stress, problem-solving coping skills and relaxation
therapy to help support COPD patients experiencing
stressful life events.
In conclusion, the present study found that life event
stress was associated with more depressive symptoms and
worse quality of life in individuals with COPD, much
more than in those without COPD. Further studies
should explore the role of cognitive appraisal of stress,
coping resources and psycho-social support in this
relationship.
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